Riskpilot← Back to searchSign inGet full accessNORSESENSE AS
ASActiveOrg 915161650Kaien 1, 4250 KopervikWholesale of pharmaceutical and medical goods · NACE 4646Est. 20150 employeeswww.norsesense.no
Revenue 2023
NOK 306K
+20% vs 2022
EBITDA margin
-3.4%
+46% vs 2022
Equity ratio
100.0%
Financial strength
Net profit 2023
NOK -15K
+24% vs 2022
| Revenue | NOK 306K | +20% |
| EBITDA | NOK -11K | +46% |
| Net profit | NOK -15K | +24% |
| Total assets | NOK 8K | -70% |
| Equity | NOK 8K | -65% |
| Employees | 0 | — |
Legal name
NORSESENSE AS
Org number
915161650
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. april 2015
Share capital
NOK 120 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Selge legionellatester og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Kaien 1, 4250 Kopervik
Website
www.norsesense.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 246 | 412 | 390 | 525 | 354 | 223 | 255 | 306 |
| Staff expenses | −0 | 9 | −0 | −0 | −0 | −0 | −0 | −5 | −5 |
| EBITDA | −46 | 38 | 33 | 30 | 6 | 5 | −106 | −19 | −11 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −46 | 38 | 33 | 30 | 6 | 5 | −106 | −19 | −11 |
| Net financials | 0 | −5 | −11 | 1 | −4 | −3 | 2 | 0 | −4 |
| Profit before tax | −46 | 33 | 22 | 31 | 2 | 3 | −104 | −19 | −15 |
| Tax | −0 | −0 | −0 | 7 | 0 | 1 | −0 | −0 | −0 |
| Net profit | −46 | 33 | 23 | 24 | 1 | 2 | −104 | −19 | −15 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 73 | 107 | 156 | 284 | 169 | 176 | 42 | 26 | 8 |
| Equity | 64 | 96 | 119 | 143 | 144 | 146 | 42 | 22 | 8 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 9 | 11 | 37 | 141 | 25 | 31 | 0 | 4 | 0 |
| Total debt | 9 | 11 | 37 | 141 | 25 | 31 | 0 | 4 | 0 |
EBITDA margin
-3.4%
This company
15.8%
Market median
-122% vs market
20152023
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20152023
Return on equity
-184.8%
This company
18.4%
Market median
-1104% vs market
20152023
Net profit margin
-4.8%
This company
8.1%
Market median
-159% vs market
20152023
Asset turnover
38.88×
This company
1.12×
Market median
+3371% vs market
20152023
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-02-18 – 2015-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2016 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Contain Invest As | Company | 55.0% | 55.0% | 2022 |
Hantho Holding As | Company | 20.0% | 20.0% | 2022 |
Makrotek As | Company | 20.0% | 20.0% | 2022 |
| Individual | 2.5% | 2.5% | 2022 | |
| Individual | 2.5% | 2.5% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Contain Invest As
NORSESENSE AS Board members of NORSESENSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tor Petter Eriksen | Chairman | 0 companies |
| Johan Petter Nielsen | Board of Directors | 0 companies |
| Anton Dahl Nielsen | Chairman | 0 companies |